N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide

C161H155F15N26O16 — CID 159101787

About N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide

N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide (PubChem CID 159101787) has the molecular formula C161H155F15N26O16 and a molecular weight of 2995.15 g/mol. Its IUPAC name is N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide.

Molecular Properties

• Compound Name: N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide
• PubChem CID: 159101787
• Molecular Formula: C161H155F15N26O16
• Molecular Weight: 2995.15 g/mol
• Exact Mass: 2993.19
• IUPAC Name: N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide
• SMILES: CC1CCCN(c2nc(C(F)(F)F)c(C(=O)Nc3ccc(N4CCC(n5c(=O)n(C)c6ccccc65)CC4)nc3)o2)C1.COc1ccccc1NC(=O)c1ccc(-c2ccc(NC(=O)c3oc(N4CCCC(C)C4)nc3C(F)(F)F)cc2)cc1.Cc1ccccc1NC(=O)c1ccc(-c2ccc(NC(=O)c3oc(N4CCC(c5ccccc5)CC4)nc3C(F)(F)F)cc2)cc1.Cc1ccccc1NC(=O)c1ccc(-c2ccc(NC(=O)c3oc(N4CCCC(C)C4)nc3C(F)(F)F)cc2)cc1.Cn1c(=O)n(C2CCN(c3ccc(NC(=O)c4oc(N5CCC(c6ccccc6)CC5)nc4C(F)(F)F)cn3)CC2)c2ccccc21
• InChI: InChI=1S/C36H31F3N4O3.C34H34F3N7O3.C31H29F3N4O4.C31H29F3N4O3.C29H32F3N7O3/c1-23-7-5-6-10-30(23)41-33(44)28-13-11-25(12-14-28)26-15-17-29(18-16-26)40-34(45)31-32(36(37,38)39)42-35(46-31)43-21-19-27(20-22-43)24-8-3-2-4-9-24;1-41-26-9-5-6-10-27(26)44(33(41)46)25-15-19-42(20-16-25)28-12-11-24(21-38-28)39-31(45)29-30(34(35,36)37)40-32(47-29)43-17-13-23(14-18-43)22-7-3-2-4-8-22;1-19-6-5-17-38(18-19)30-37-27(31(32,33)34)26(42-30)29(40)35-23-15-13-21(14-16-23)20-9-11-22(12-10-20)28(39)36-24-7-3-4-8-25(24)41-2;1-19-6-5-17-38(18-19)30-37-27(31(32,33)34)26(41-30)29(40)35-24-15-13-22(14-16-24)21-9-11-23(12-10-21)28(39)36-25-8-4-3-7-20(25)2;1-18-6-5-13-38(17-18)27-35-25(29(30,31)32)24(42-27)26(40)34-19-9-10-23(33-16-19)37-14-11-20(12-15-37)39-22-8-4-3-7-21(22)36(2)28(39)41/h2-18,27H,19-22H2,1H3,(H,40,45)(H,41,44);2-12,21,23,25H,13-20H2,1H3,(H,39,45);3-4,7-16,19H,5-6,17-18H2,1-2H3,(H,35,40)(H,36,39);3-4,7-16,19H,5-6,17-18H2,1-2H3,(H,35,40)(H,36,39);3-4,7-10,16,18,20H,5-6,11-15,17H2,1-2H3,(H,34,40)
• InChIKey: KDJNMRBTDDZXOW-UHFFFAOYSA-N
• XLogP: 34.37
• TPSA: 474.50 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 34
• Rotatable Bonds: 31
• Heavy Atoms: 218
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2995.15
LogP ≤ 5	34.37
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	34

Frequently Asked Questions

What is the IUPAC name of N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide?

The IUPAC name of N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide (CID 159101787) is N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide.

What is the SMILES notation for N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide?

The canonical SMILES for N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide is CC1CCCN(c2nc(C(F)(F)F)c(C(=O)Nc3ccc(N4CCC(n5c(=O)n(C)c6ccccc65)CC4)nc3)o2)C1.COc1ccccc1NC(=O)c1ccc(-c2ccc(NC(=O)c3oc(N4CCCC(C)C4)nc3C(F)(F)F)cc2)cc1.Cc1ccccc1NC(=O)c1ccc(-c2ccc(NC(=O)c3oc(N4CCC(c5ccccc5)CC4)nc3C(F)(F)F)cc2)cc1.Cc1ccccc1NC(=O)c1ccc(-c2ccc(NC(=O)c3oc(N4CCCC(C)C4)nc3C(F)(F)F)cc2)cc1.Cn1c(=O)n(C2CCN(c3ccc(NC(=O)c4oc(N5CCC(c6ccccc6)CC5)nc4C(F)(F)F)cn3)CC2)c2ccccc21.

What is the InChIKey of N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide?

The InChIKey is KDJNMRBTDDZXOW-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H31F3N4O3.C34H34F3N7O3.C31H29F3N4O4.C31H29F3N4O3.C29H32F3N7O3/c1-23-7-5-6-10-30(23)41-33(44)28-13-11-25(12-14-28)26-15-17-29(18-16-26)40-34(45)31-32(36(37,38)39)42-35(46-31)43-21-19-27(20-22-43)24-8-3-2-4-9-24;1-41-26-9-5-6-10-27(26)44(33(41)46)25-15-19-42(20-16-25)28-12-11-24(21-38-28)39-31(45)29-30(34(35,36)37)40-32(47-29)43-17-13-23(14-18-43)22-7-3-2-4-8-22;1-19-6-5-17-38(18-19)30-37-27(31(32,33)34)26(42-30)29(40)35-23-15-13-21(14-16-23)20-9-11-22(12-10-20)28(39)36-24-7-3-4-8-25(24)41-2;1-19-6-5-17-38(18-19)30-37-27(31(32,33)34)26(41-30)29(40)35-24-15-13-22(14-16-24)21-9-11-23(12-10-21)28(39)36-25-8-4-3-7-20(25)2;1-18-6-5-13-38(17-18)27-35-25(29(30,31)32)24(42-27)26(40)34-19-9-10-23(33-16-19)37-14-11-20(12-15-37)39-22-8-4-3-7-21(22)36(2)28(39)41/h2-18,27H,19-22H2,1H3,(H,40,45)(H,41,44);2-12,21,23,25H,13-20H2,1H3,(H,39,45);3-4,7-16,19H,5-6,17-18H2,1-2H3,(H,35,40)(H,36,39);3-4,7-16,19H,5-6,17-18H2,1-2H3,(H,35,40)(H,36,39);3-4,7-10,16,18,20H,5-6,11-15,17H2,1-2H3,(H,34,40).

What are the key properties of N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide?

N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide has a molecular weight of 2995.15 g/mol, XLogP of 34.37, 31 rotatable bonds, 8 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for N-[4-[4-[(2-methoxyphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[4-(3-methyl-2-oxobenzimidazol-1-yl)piperidin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[4-[4-[(2-methylphenyl)carbamoyl]phenyl]phenyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide is sourced from PubChem (CID 159101787), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).